Rebalance’s Vanguard FTSE Developed Markets ETF VEA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$118M Buy
1,661,823
+71,931
+5% +$5.01M 6.21% 5
2026
Q1
$102M Sell
1,589,892
-21,413
-1% -$1.41M 5.92% 5
2025
Q4
$101M Buy
1,611,305
+22,344
+1% +$1.37M 5.88% 5
2025
Q3
$95.2M Buy
1,588,961
+45,691
+3% +$2.66M 5.74% 5
2025
Q2
$88M Sell
1,543,270
-210,828
-12% -$11.3M 5.98% 5
2025
Q1
$89.2M Buy
1,754,098
+4,638
+0.3% +$235K 6.57% 5
2024
Q4
$83.7M Buy
1,749,460
+52,651
+3% +$2.64M 6.25% 5
2024
Q3
$89.6M Buy
1,696,809
+14,443
+0.9% +$734K 6.56% 6
2024
Q2
$83.1M Buy
1,682,366
+35,860
+2% +$1.78M 6.69% 5
2024
Q1
$82.6M Buy
1,646,506
+31,982
+2% +$1.54M 6.79% 4
2023
Q4
$77.3M Buy
1,614,524
+70,424
+5% +$3.15M 6.74% 5
2023
Q3
$67.5M Buy
1,544,100
+46,820
+3% +$2.14M 6.57% 5
2023
Q2
$69.1M Sell
1,497,280
-136,309
-8% -$6.27M 6.56% 5
2023
Q1
$73.8M Buy
1,633,589
+31,850
+2% +$1.42M 7.3% 4
2022
Q4
$67.2M Buy
+1,601,739
New +$64.9M 6.98% 4

Other funds holding VEA

Rebalance's VEA Position: Q2 2026 in Review

Rebalance increased its Vanguard FTSE Developed Markets ETF (VEA) stake by 4.5% in Q2 2026, buying an estimated $5.01M and bringing the position to 1,661,823 shares worth $118M. The position accounts for 6.21% of the portfolio, ranked #5.

Rebalance first reported a position in VEA in Q4 2022 and has held it in 15 quarters since. 2,984 funds tracked by Wall St. Rank hold VEA as of Q2 2026.

  • Rebalance held 1,661,823 shares of Vanguard FTSE Developed Markets ETF worth $118M as of Q2 2026.
  • Rebalance bought 71,931 Vanguard FTSE Developed Markets ETF shares in Q2 2026, an estimated $5.01M.
  • Vanguard FTSE Developed Markets ETF made up 6.21% of Rebalance's portfolio in Q2 2026, its #5 holding.
  • Rebalance first reported a position in Vanguard FTSE Developed Markets ETF in Q4 2022 and has held it in 15 quarters since.
  • 2,984 funds tracked by Wall St. Rank held Vanguard FTSE Developed Markets ETF as of Q2 2026.

Based on Rebalance's 13F filing for Q2 2026, filed 16 Jul 2026.